Changes in Hepatic Fat Content by CT 1 Year After Sleeve Gastrectomy in Adolescents and Young Adults With Obesity
© The Author(s) 2023. Published by Oxford University Press on behalf of the Endocrine Society. All rights reserved. For permissions, please e-mail: journals.permissionsoup.com..
CONTEXT: Obesity is associated with nonalcoholic fatty liver disease (NAFLD). Sleeve gastrectomy (SG) is an effective means of weight loss and improvement of NAFLD in adults; however, data regarding the efficacy of SG in the early stages of pediatric NAFLD are sparse.
OBJECTIVE: To assess the impact of SG on hepatic fat content 1 year after SG in youth with obesity compared with nonsurgical controls with obesity (NS).
DESIGN: A 12-month prospective study in 52 participants (mean age, 18.2 ± .36 years) with obesity, comprising 25 subjects who underwent SG (84% female; median body mass index [BMI], 44.6 [42.1-47.9] kg/m2) and 27 who were NS (70% female; median BMI, 42.2 [38.7-47.0] kg/m2).
MAIN OUTCOME MEASURES: Hepatic fat content by computed tomography (liver/spleen ratio), abdominal fat by magnetic resonance imaging.
RESULTS: Mean 12-month decrease in BMI was greater in SG vs NS (-12.5 ± .8 vs -.2 ± .5 kg/m2, P < .0001). There was a within-group increase in the liver-to-spleen (L/S) ratio in SG (.13 ± .05, P = .014) but not NS with a trend for a difference between groups (P = .055). All SG participants with an L/S ratio <1.0 (threshold for the diagnosis of NAFLD) before surgery had a ratio of >1.0 a year after surgery, consistent with resolution of NAFLD. Within SG, the 12-month change in L/S ratio was negatively associated with 12-month change in visceral fat (ρ = -.51 P = .016).
CONCLUSIONS: Hepatic fat content as assessed by noncontrast computed tomography improved after SG over 1 year in youth with obesity with resolution of NAFLD in all subjects. This was associated with decreases in visceral adiposity.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2023 |
---|---|
Erschienen: |
2023 |
Enthalten in: |
Zur Gesamtaufnahme - volume:108 |
---|---|
Enthalten in: |
The Journal of clinical endocrinology and metabolism - 108(2023), 12 vom: 17. Nov., Seite e1489-e1495 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
López López, Ana Paola [VerfasserIn] |
---|
Links: |
---|
Themen: |
Adolescents |
---|
Anmerkungen: |
Date Completed 20.11.2023 Date Revised 29.01.2024 published: Print Citation Status MEDLINE |
---|
doi: |
10.1210/clinem/dgad390 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM359043887 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM359043887 | ||
003 | DE-627 | ||
005 | 20240129231836.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2023 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1210/clinem/dgad390 |2 doi | |
028 | 5 | 2 | |a pubmed24n1274.xml |
035 | |a (DE-627)NLM359043887 | ||
035 | |a (NLM)37403207 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a López López, Ana Paola |e verfasserin |4 aut | |
245 | 1 | 0 | |a Changes in Hepatic Fat Content by CT 1 Year After Sleeve Gastrectomy in Adolescents and Young Adults With Obesity |
264 | 1 | |c 2023 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 20.11.2023 | ||
500 | |a Date Revised 29.01.2024 | ||
500 | |a published: Print | ||
500 | |a Citation Status MEDLINE | ||
520 | |a © The Author(s) 2023. Published by Oxford University Press on behalf of the Endocrine Society. All rights reserved. For permissions, please e-mail: journals.permissionsoup.com. | ||
520 | |a CONTEXT: Obesity is associated with nonalcoholic fatty liver disease (NAFLD). Sleeve gastrectomy (SG) is an effective means of weight loss and improvement of NAFLD in adults; however, data regarding the efficacy of SG in the early stages of pediatric NAFLD are sparse | ||
520 | |a OBJECTIVE: To assess the impact of SG on hepatic fat content 1 year after SG in youth with obesity compared with nonsurgical controls with obesity (NS) | ||
520 | |a DESIGN: A 12-month prospective study in 52 participants (mean age, 18.2 ± .36 years) with obesity, comprising 25 subjects who underwent SG (84% female; median body mass index [BMI], 44.6 [42.1-47.9] kg/m2) and 27 who were NS (70% female; median BMI, 42.2 [38.7-47.0] kg/m2) | ||
520 | |a MAIN OUTCOME MEASURES: Hepatic fat content by computed tomography (liver/spleen ratio), abdominal fat by magnetic resonance imaging | ||
520 | |a RESULTS: Mean 12-month decrease in BMI was greater in SG vs NS (-12.5 ± .8 vs -.2 ± .5 kg/m2, P < .0001). There was a within-group increase in the liver-to-spleen (L/S) ratio in SG (.13 ± .05, P = .014) but not NS with a trend for a difference between groups (P = .055). All SG participants with an L/S ratio <1.0 (threshold for the diagnosis of NAFLD) before surgery had a ratio of >1.0 a year after surgery, consistent with resolution of NAFLD. Within SG, the 12-month change in L/S ratio was negatively associated with 12-month change in visceral fat (ρ = -.51 P = .016) | ||
520 | |a CONCLUSIONS: Hepatic fat content as assessed by noncontrast computed tomography improved after SG over 1 year in youth with obesity with resolution of NAFLD in all subjects. This was associated with decreases in visceral adiposity | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a adolescents | |
650 | 4 | |a computed tomography (CT) | |
650 | 4 | |a metabolic and bariatric surgery (MBS) | |
650 | 4 | |a nonalcoholic fatty liver disease (NAFLD) | |
650 | 4 | |a obesity | |
650 | 4 | |a sleeve gastrectomy | |
700 | 1 | |a Tuli, Shubhangi |e verfasserin |4 aut | |
700 | 1 | |a Lauze, Meghan |e verfasserin |4 aut | |
700 | 1 | |a Becetti, Imen |e verfasserin |4 aut | |
700 | 1 | |a Pedreira, Clarissa C |e verfasserin |4 aut | |
700 | 1 | |a Huber, Florian A |e verfasserin |4 aut | |
700 | 1 | |a Omeroglu, Emre |e verfasserin |4 aut | |
700 | 1 | |a Singhal, Vibha |e verfasserin |4 aut | |
700 | 1 | |a Misra, Madhusmita |e verfasserin |4 aut | |
700 | 1 | |a Bredella, Miriam A |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t The Journal of clinical endocrinology and metabolism |d 1945 |g 108(2023), 12 vom: 17. Nov., Seite e1489-e1495 |w (DE-627)NLM00001821X |x 1945-7197 |7 nnns |
773 | 1 | 8 | |g volume:108 |g year:2023 |g number:12 |g day:17 |g month:11 |g pages:e1489-e1495 |
856 | 4 | 0 | |u http://dx.doi.org/10.1210/clinem/dgad390 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 108 |j 2023 |e 12 |b 17 |c 11 |h e1489-e1495 |